- Home
- AUPH vs TASK Comparison
AUPH vs TASK Comparison
Compare AUPH & TASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- TASK
- Stock Information
- Founded
- AUPH 1993
- TASK 2008
- Country
- AUPH Canada
- TASK United States
- Employees
- AUPH N/A
- TASK N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- TASK Retail: Computer Software & Peripheral Equipment
- Sector
- AUPH Health Care
- TASK Technology
- Exchange
- AUPH Nasdaq
- TASK Nasdaq
- Market Cap
- AUPH 1.4B
- TASK 1.5B
- IPO Year
- AUPH 1999
- TASK 2021
- Fundamental
- Price
- AUPH $12.83
- TASK $17.51
- Analyst Decision
- AUPH Strong Buy
- TASK Buy
- Analyst Count
- AUPH 3
- TASK 4
- Target Price
- AUPH $12.00
- TASK $16.88
- AVG Volume (30 Days)
- AUPH 1.5M
- TASK 481.2K
- Earning Date
- AUPH 11-06-2025
- TASK 11-06-2025
- Dividend Yield
- AUPH N/A
- TASK N/A
- EPS Growth
- AUPH N/A
- TASK 21.25
- EPS
- AUPH 0.42
- TASK 0.67
- Revenue
- AUPH $260,111,000.00
- TASK $1,101,465,000.00
- Revenue This Year
- AUPH $16.92
- TASK $19.10
- Revenue Next Year
- AUPH $14.43
- TASK $11.73
- P/E Ratio
- AUPH $29.12
- TASK $25.99
- Revenue Growth
- AUPH 25.59
- TASK 19.04
- 52 Week Low
- AUPH $6.55
- TASK $10.57
- 52 Week High
- AUPH $12.90
- TASK $19.60
- Technical
- Relative Strength Index (RSI)
- AUPH 63.83
- TASK 51.61
- Support Level
- AUPH $12.18
- TASK $17.40
- Resistance Level
- AUPH $12.90
- TASK $17.68
- Average True Range (ATR)
- AUPH 0.42
- TASK 0.27
- MACD
- AUPH -0.06
- TASK -0.04
- Stochastic Oscillator
- AUPH 92.89
- TASK 34.33
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About TASK TaskUs Inc.
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world-wide Game-changing companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.